Evidence map›Paper›PMID 39482734›Full record

ArticleGenome biology2024

Benchmarking and building DNA binding affinity models using allele-specific and allele-agnostic transcription factor binding data.

Xiaoting Li, Lucas A N Melo, Harmen J Bussemaker

Abstract read
In one paragraph

Article in Genome biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Xiaoting Li *Department of Biological Sciences, Columbia University, New York, NY, 10027, USA.ORCID 0000-0003-4938-7587
Lucas A N Melo *Department of Biological Sciences, Columbia University, New York, NY, 10027, USA.ORCID 0000-0002-7563-7554
Harmen J BussemakerDepartment of Biological Sciences, Columbia University, New York, NY, 10027, USA. hjb2004@columbia.edu.ORCID 0000-0002-7274-5277

Funding

Statistical models for fine-mapping and interpretation of schizophrenia-associated lociR01MH106842 · NIMH · NEW YORK GENOME CENTER · PI BUSSEMAKER, HARMEN J, LAPPALAINEN, TUULI · 2015 to 2024
$5.0M
NIMH NIH HHS R01 MH106842NIMH NIH HHS R01MH106842
6 · The paper itself

Abstract

backgroundTranscription factors (TFs) bind to DNA in a highly sequence-specific manner. This specificity manifests itself in vivo as differences in TF occupancy between the two alleles at heterozygous loci. Genome-scale assays such as ChIP-seq currently are limited in their power to detect allele-specific binding (ASB) both in terms of read coverage and representation of individual variants in the cell lines used. This makes prediction of allelic differences in TF binding from sequence alone desirable, provided that the reliability of such predictions can be quantitatively assessed.

resultsWe here propose methods for benchmarking sequence-to-affinity models for TF binding in terms of their ability to predict allelic imbalances in ChIP-seq counts. We use a likelihood function based on an over-dispersed binomial distribution to aggregate evidence for allelic preference across the genome without requiring statistical significance for individual variants. This allows us to systematically compare predictive performance when multiple binding models for the same TF are available. To facilitate the de novo inference of high-quality models from paired-end in vivo binding data such as ChIP-seq, ChIP-exo, and CUT&Tag without read mapping or peak calling, we introduce an extensible reimplementation of our biophysically interpretable machine learning framework named PyProBound. Explicitly accounting for assay-specific bias in DNA fragmentation rate when training on ChIP-seq yields improved TF binding models. Moreover, we show how PyProBound can leverage our threshold-free ASB likelihood function to perform de novo motif discovery using allele-specific ChIP-seq counts.

conclusionOur work provides new strategies for predicting the functional impact of non-coding variants.

Indexed as

AllelesBenchmarkingChromatin Immunoprecipitation SequencingDNATranscription FactorsBinding SitesHumansProtein BindingDNATranscription FactorsAllele-specific bindingBiophysically interpretable machine learningChIP-seq, ChIP-exo, CUT&TagCTCF, EBF1, PU.1/SPI1Gene expression regulationMotif discoveryNon-coding variantsStatistical modelingTranscription factors

Identifiers

PMID39482734
PMCPMC11529166

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.